Emma Johnson is the founder of Essential Pharma Group. Essential Pharma Group has raised $966M in total funding. Latest round: Growth. Based in Egham, UK.
Emma Johnson is the CEO of Essential Pharma, an international specialty pharma group that focuses on providing access to low-volume, clinically differentiated, niche pharmaceutical products. The company secured a €900 million recapitalization in December 2024 through a Gyrus Capital Continuation Vehicle, led by AlpInvest, and new strategic financing from Sixth Street. Johnson was appointed CEO in 2023 and has since led the company's expansion into rare diseases, including the addition of Colobreathe® and Hu14.18.
Full founder directory · Investor directory · Company funding database · Fundraising library